

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.97516594 |
| 2 | interferon-gamma production (GO:0032609) | 4.47301598 |
| 3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.42751575 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33177399 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.33177399 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.31764842 |
| 7 | fucose catabolic process (GO:0019317) | 4.26132344 |
| 8 | L-fucose metabolic process (GO:0042354) | 4.26132344 |
| 9 | L-fucose catabolic process (GO:0042355) | 4.26132344 |
| 10 | mannose metabolic process (GO:0006013) | 4.23996100 |
| 11 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 4.03323243 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.94459020 |
| 13 | regulation of response to interferon-gamma (GO:0060330) | 3.85720524 |
| 14 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.82385400 |
| 15 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.80770646 |
| 16 | fucose metabolic process (GO:0006004) | 3.70188067 |
| 17 | vitamin transmembrane transport (GO:0035461) | 3.63746478 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 3.55553786 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53416481 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.53252237 |
| 21 | tolerance induction (GO:0002507) | 3.47114169 |
| 22 | glucose 6-phosphate metabolic process (GO:0051156) | 3.46050601 |
| 23 | cellular response to exogenous dsRNA (GO:0071360) | 3.43123701 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.39945166 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39556828 |
| 26 | response to type I interferon (GO:0034340) | 3.39024956 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 3.38667721 |
| 28 | type I interferon signaling pathway (GO:0060337) | 3.36533915 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.36533915 |
| 30 | embryonic process involved in female pregnancy (GO:0060136) | 3.32457367 |
| 31 | fucosylation (GO:0036065) | 3.29376442 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.25173439 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.25173439 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.25173439 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.25173439 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 3.25173439 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.25173439 |
| 38 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.24803190 |
| 39 | negative regulation of innate immune response (GO:0045824) | 3.21327834 |
| 40 | GDP-mannose metabolic process (GO:0019673) | 3.19804280 |
| 41 | positive regulation of granulocyte differentiation (GO:0030854) | 3.19443080 |
| 42 | response to peptidoglycan (GO:0032494) | 3.11419449 |
| 43 | regulation of defense response to virus by host (GO:0050691) | 3.10600128 |
| 44 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.04215564 |
| 45 | response to laminar fluid shear stress (GO:0034616) | 2.98451337 |
| 46 | response to interleukin-15 (GO:0070672) | 2.98235320 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 2.98052502 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95544251 |
| 49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94724014 |
| 50 | positive regulation of interferon-beta production (GO:0032728) | 2.88984852 |
| 51 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.88958626 |
| 52 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.88951552 |
| 53 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87854375 |
| 54 | germinal center formation (GO:0002467) | 2.87837721 |
| 55 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.84380865 |
| 56 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.83533277 |
| 57 | negative regulation of stress fiber assembly (GO:0051497) | 2.80986284 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 2.77879524 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73388072 |
| 60 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.70949972 |
| 61 | cellular response to virus (GO:0098586) | 2.69992966 |
| 62 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.69939779 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 2.69549698 |
| 64 | iron-sulfur cluster assembly (GO:0016226) | 2.67045398 |
| 65 | metallo-sulfur cluster assembly (GO:0031163) | 2.67045398 |
| 66 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.66917151 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65488301 |
| 68 | cellular response to dsRNA (GO:0071359) | 2.63750537 |
| 69 | negative regulation of glial cell proliferation (GO:0060253) | 2.63258047 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.62288294 |
| 71 | lipoxygenase pathway (GO:0019372) | 2.61794442 |
| 72 | positive regulation of Notch signaling pathway (GO:0045747) | 2.61637943 |
| 73 | amino sugar catabolic process (GO:0046348) | 2.61539705 |
| 74 | regulation of superoxide anion generation (GO:0032928) | 2.60344621 |
| 75 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.60140097 |
| 76 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.60140097 |
| 77 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.58887441 |
| 78 | positive regulation of cholesterol efflux (GO:0010875) | 2.58770366 |
| 79 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.58520168 |
| 80 | regulation of cholesterol storage (GO:0010885) | 2.56379356 |
| 81 | alpha-beta T cell differentiation (GO:0046632) | 2.56254019 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.56007454 |
| 83 | negative regulation of myotube differentiation (GO:0010832) | 2.55760274 |
| 84 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.55728744 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 2.52906893 |
| 86 | defense response to protozoan (GO:0042832) | 2.52777204 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52604331 |
| 88 | positive regulation of mitochondrial fission (GO:0090141) | 2.52461355 |
| 89 | mature B cell differentiation involved in immune response (GO:0002313) | 2.51828323 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 2.51699709 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.50123253 |
| 92 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49839062 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.49664355 |
| 94 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.46835484 |
| 95 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.45890010 |
| 96 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.45537597 |
| 97 | amyloid precursor protein catabolic process (GO:0042987) | 2.45503737 |
| 98 | response to protozoan (GO:0001562) | 2.45187336 |
| 99 | positive regulation of macrophage differentiation (GO:0045651) | 2.44535142 |
| 100 | negative thymic T cell selection (GO:0045060) | 2.42685079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.30115276 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.19619328 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.78767133 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72584661 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58580015 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.43580304 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34787459 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31315110 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30404089 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10353626 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09509264 |
| 12 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05276011 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01293879 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.01174838 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99452283 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98893164 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93436859 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89193249 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 1.88925759 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.86606882 |
| 21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.75827995 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74852529 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73651647 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70737440 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70421483 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70283391 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68848543 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67762916 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67215113 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65804758 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64336852 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64167913 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63237296 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62520546 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60288982 |
| 36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58977906 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.55274333 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54279573 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54128344 |
| 40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54116003 |
| 41 | P68_20966046_ChIP-Seq_HELA_Human | 1.52179666 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50830978 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45230928 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42398960 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41044522 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40025738 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39990099 |
| 48 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.39180756 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38162013 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.36641898 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34774872 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34337724 |
| 53 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34313850 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33050148 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31020229 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29928034 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28969914 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28129555 |
| 59 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23928927 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20936587 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20621742 |
| 62 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20475309 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16878936 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16000246 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14332371 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13961028 |
| 67 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13951452 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13782078 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13131322 |
| 70 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.12726439 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11126161 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10530695 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09857224 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09544628 |
| 75 | P300_27268052_Chip-Seq_Bcells_Human | 1.08210449 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07177571 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06992043 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06403974 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05751650 |
| 80 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05607879 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05355517 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05172149 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05145151 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04592633 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04478379 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03658577 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03320376 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02338372 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01446486 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01045484 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00919232 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00719381 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00158042 |
| 94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99894909 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99847202 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99820087 |
| 97 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99375498 |
| 98 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98712696 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97848385 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97702625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 4.26230770 |
| 2 | MP0009840_abnormal_foam_cell | 3.84962110 |
| 3 | MP0003724_increased_susceptibility_to | 3.55878665 |
| 4 | MP0002653_abnormal_ependyma_morphology | 3.28751636 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.22241524 |
| 6 | MP0008260_abnormal_autophagy | 2.91421682 |
| 7 | MP0003436_decreased_susceptibility_to | 2.88001501 |
| 8 | MP0000685_abnormal_immune_system | 2.77781084 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.74569879 |
| 10 | MP0009278_abnormal_bone_marrow | 2.72554339 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.71038443 |
| 12 | MP0005387_immune_system_phenotype | 2.60832643 |
| 13 | MP0001790_abnormal_immune_system | 2.60832643 |
| 14 | MP0005025_abnormal_response_to | 2.45698941 |
| 15 | MP0002419_abnormal_innate_immunity | 2.41508948 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.38733086 |
| 17 | MP0004381_abnormal_hair_follicle | 2.36733394 |
| 18 | MP0000858_altered_metastatic_potential | 2.31760314 |
| 19 | MP0001800_abnormal_humoral_immune | 2.31693277 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.29073293 |
| 21 | MP0004947_skin_inflammation | 2.24817692 |
| 22 | MP0005671_abnormal_response_to | 2.22747081 |
| 23 | MP0002009_preneoplasia | 2.20493025 |
| 24 | MP0002723_abnormal_immune_serum | 2.18781474 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.18408829 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.17660603 |
| 27 | MP0003303_peritoneal_inflammation | 2.13805628 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.04104939 |
| 29 | MP0009785_altered_susceptibility_to | 2.03851530 |
| 30 | MP0001819_abnormal_immune_cell | 1.94059621 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.92144601 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.91280241 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.87140501 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.74243929 |
| 35 | MP0002405_respiratory_system_inflammati | 1.64275538 |
| 36 | MP0006082_CNS_inflammation | 1.64108776 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.61061694 |
| 38 | MP0003646_muscle_fatigue | 1.58374480 |
| 39 | MP0004510_myositis | 1.57842728 |
| 40 | MP0000716_abnormal_immune_system | 1.50588100 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.48912210 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.43100279 |
| 43 | MP0003866_abnormal_defecation | 1.42959039 |
| 44 | MP0000604_amyloidosis | 1.40084467 |
| 45 | MP0005310_abnormal_salivary_gland | 1.36091749 |
| 46 | MP0002398_abnormal_bone_marrow | 1.35283310 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.34090138 |
| 48 | MP0009764_decreased_sensitivity_to | 1.34079483 |
| 49 | MP0003329_amyloid_beta_deposits | 1.28551558 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.26568049 |
| 51 | MP0001849_ear_inflammation | 1.22695324 |
| 52 | MP0002429_abnormal_blood_cell | 1.21392978 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.21215062 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.18316931 |
| 55 | MP0005451_abnormal_body_composition | 1.15724374 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.15535546 |
| 57 | MP0008469_abnormal_protein_level | 1.15481495 |
| 58 | MP0002722_abnormal_immune_system | 1.11884055 |
| 59 | MP0004742_abnormal_vestibular_system | 1.08314818 |
| 60 | MP0001873_stomach_inflammation | 1.05982417 |
| 61 | MP0003448_altered_tumor_morphology | 1.05906649 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.05353768 |
| 63 | MP0000490_abnormal_crypts_of | 1.04919794 |
| 64 | MP0002254_reproductive_system_inflammat | 1.03239900 |
| 65 | MP0002132_abnormal_respiratory_system | 1.00719097 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.97705595 |
| 67 | MP0002006_tumorigenesis | 0.97385241 |
| 68 | MP0009763_increased_sensitivity_to | 0.94922228 |
| 69 | MP0006054_spinal_hemorrhage | 0.94145359 |
| 70 | MP0005390_skeleton_phenotype | 0.85604700 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.83004208 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.83004208 |
| 73 | MP0001216_abnormal_epidermal_layer | 0.81973313 |
| 74 | MP0003075_altered_response_to | 0.80779133 |
| 75 | MP0001853_heart_inflammation | 0.80778417 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.80629577 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.78849606 |
| 78 | MP0000343_altered_response_to | 0.78393896 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77066630 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.76210245 |
| 81 | MP0003195_calcinosis | 0.75707004 |
| 82 | MP0003828_pulmonary_edema | 0.75615820 |
| 83 | MP0000750_abnormal_muscle_regeneration | 0.73963654 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.71705291 |
| 85 | MP0003795_abnormal_bone_structure | 0.70865181 |
| 86 | MP0001243_abnormal_dermal_layer | 0.69862091 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.68557031 |
| 88 | MP0005394_taste/olfaction_phenotype | 0.68246133 |
| 89 | MP0005499_abnormal_olfactory_system | 0.68246133 |
| 90 | MP0004133_heterotaxia | 0.67746105 |
| 91 | MP0002933_joint_inflammation | 0.66815508 |
| 92 | MP0001915_intracranial_hemorrhage | 0.65318363 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.64285012 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.63408970 |
| 95 | MP0003091_abnormal_cell_migration | 0.61171480 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.59783409 |
| 97 | MP0001851_eye_inflammation | 0.59080417 |
| 98 | MP0000249_abnormal_blood_vessel | 0.57359876 |
| 99 | MP0004130_abnormal_muscle_cell | 0.56247382 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.53956166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mutism (HP:0002300) | 5.05149745 |
| 2 | Pustule (HP:0200039) | 5.03385728 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.43158500 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.80578417 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.64692933 |
| 6 | Abnormal tarsal ossification (HP:0008369) | 3.38357040 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.36803645 |
| 8 | Myositis (HP:0100614) | 3.34575115 |
| 9 | Hypoplasia of the pons (HP:0012110) | 3.32807507 |
| 10 | Hemorrhage of the eye (HP:0011885) | 3.27546342 |
| 11 | Ragged-red muscle fibers (HP:0003200) | 3.26453660 |
| 12 | Urethral obstruction (HP:0000796) | 3.20269413 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.19942161 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.07431916 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.02841376 |
| 16 | Orchitis (HP:0100796) | 2.88278762 |
| 17 | Abnormality of the pons (HP:0007361) | 2.85443371 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 2.85001432 |
| 19 | Flat acetabular roof (HP:0003180) | 2.81882111 |
| 20 | Loss of speech (HP:0002371) | 2.76892625 |
| 21 | Increased IgE level (HP:0003212) | 2.74086407 |
| 22 | Chronic diarrhea (HP:0002028) | 2.72560432 |
| 23 | Progressive sensorineural hearing impairment (HP:0000408) | 2.67602364 |
| 24 | Colon cancer (HP:0003003) | 2.66944328 |
| 25 | Recurrent skin infections (HP:0001581) | 2.62879412 |
| 26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.54450776 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.53731382 |
| 28 | Optic neuritis (HP:0100653) | 2.53731382 |
| 29 | Stomach cancer (HP:0012126) | 2.52921399 |
| 30 | Recurrent viral infections (HP:0004429) | 2.52637450 |
| 31 | Opisthotonus (HP:0002179) | 2.51014159 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47613927 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47613927 |
| 34 | Cholecystitis (HP:0001082) | 2.44114460 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 2.44114460 |
| 36 | Stomatitis (HP:0010280) | 2.40138425 |
| 37 | Thick nail (HP:0001805) | 2.36013482 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.33087619 |
| 39 | Upper motor neuron abnormality (HP:0002127) | 2.32835985 |
| 40 | Hepatosplenomegaly (HP:0001433) | 2.29003387 |
| 41 | Myopathic facies (HP:0002058) | 2.28853326 |
| 42 | T lymphocytopenia (HP:0005403) | 2.24439722 |
| 43 | Abnormal foot bone ossification (HP:0010675) | 2.24323791 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 2.23787947 |
| 45 | Facial diplegia (HP:0001349) | 2.22065942 |
| 46 | J-shaped sella turcica (HP:0002680) | 2.21756123 |
| 47 | Retinal dysplasia (HP:0007973) | 2.18385275 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.18320021 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18320021 |
| 50 | External ophthalmoplegia (HP:0000544) | 2.17773191 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16370385 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15946265 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15946265 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15946265 |
| 55 | Abnormality of the periventricular white matter (HP:0002518) | 2.13763225 |
| 56 | Type II lissencephaly (HP:0007260) | 2.11593828 |
| 57 | Short chin (HP:0000331) | 2.11441551 |
| 58 | Hematochezia (HP:0002573) | 2.09222616 |
| 59 | Distal upper limb amyotrophy (HP:0007149) | 2.07957632 |
| 60 | Upper limb amyotrophy (HP:0009129) | 2.07957632 |
| 61 | Flattened epiphyses (HP:0003071) | 2.05652862 |
| 62 | Combined immunodeficiency (HP:0005387) | 2.05539429 |
| 63 | Cheilitis (HP:0100825) | 2.04720775 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.03207731 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00664344 |
| 66 | Trigonocephaly (HP:0000243) | 2.00550706 |
| 67 | Spastic tetraparesis (HP:0001285) | 2.00140906 |
| 68 | Leukocytosis (HP:0001974) | 1.99020456 |
| 69 | Stridor (HP:0010307) | 1.96888879 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 1.95882675 |
| 71 | Hand muscle atrophy (HP:0009130) | 1.94232292 |
| 72 | Concave nail (HP:0001598) | 1.93716334 |
| 73 | Microvesicular hepatic steatosis (HP:0001414) | 1.93083704 |
| 74 | Neuronal loss in central nervous system (HP:0002529) | 1.92879804 |
| 75 | Abnormality of eosinophils (HP:0001879) | 1.91461273 |
| 76 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90767271 |
| 77 | Villous atrophy (HP:0011473) | 1.90767271 |
| 78 | Thoracic kyphosis (HP:0002942) | 1.89504316 |
| 79 | Agammaglobulinemia (HP:0004432) | 1.87527503 |
| 80 | Broad face (HP:0000283) | 1.86742385 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 1.86387962 |
| 82 | Cellulitis (HP:0100658) | 1.86187336 |
| 83 | Abnormality of the odontoid process (HP:0003310) | 1.85002764 |
| 84 | Lymphopenia (HP:0001888) | 1.84486234 |
| 85 | IgG deficiency (HP:0004315) | 1.83486696 |
| 86 | Axonal loss (HP:0003447) | 1.83452279 |
| 87 | Bowel incontinence (HP:0002607) | 1.81311906 |
| 88 | Meningitis (HP:0001287) | 1.80427713 |
| 89 | Abnormality of T cell number (HP:0011839) | 1.80290157 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 1.80059152 |
| 91 | Hypoalbuminemia (HP:0003073) | 1.78476206 |
| 92 | Abnormal albumin level (HP:0012116) | 1.78476206 |
| 93 | Hyperacusis (HP:0010780) | 1.78418799 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 1.77382652 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76768194 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76768194 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76768194 |
| 98 | Diaphragmatic weakness (HP:0009113) | 1.76692211 |
| 99 | Increased serum ferritin (HP:0003281) | 1.76382719 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 1.75520665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.43070332 |
| 2 | TESK2 | 3.26382050 |
| 3 | GRK7 | 3.23024026 |
| 4 | TAOK3 | 3.16383859 |
| 5 | BRD4 | 2.95092003 |
| 6 | ERN1 | 2.35570298 |
| 7 | MAP4K1 | 2.33720484 |
| 8 | SIK3 | 2.28911420 |
| 9 | MAPKAPK3 | 2.18840606 |
| 10 | MAP3K14 | 2.13941028 |
| 11 | EPHA3 | 2.00703587 |
| 12 | EPHB1 | 1.98090776 |
| 13 | PRPF4B | 1.96628140 |
| 14 | MAP3K13 | 1.81477810 |
| 15 | BLK | 1.78019083 |
| 16 | GRK6 | 1.61226126 |
| 17 | TESK1 | 1.60269021 |
| 18 | IRAK3 | 1.58064381 |
| 19 | TBK1 | 1.53822708 |
| 20 | SIK2 | 1.50482488 |
| 21 | EPHA2 | 1.50003229 |
| 22 | TRIB3 | 1.48818531 |
| 23 | TYK2 | 1.44766695 |
| 24 | STK10 | 1.38590787 |
| 25 | ICK | 1.34226817 |
| 26 | CDK6 | 1.31642513 |
| 27 | PAK4 | 1.30174769 |
| 28 | FGR | 1.29350137 |
| 29 | KDR | 1.29290090 |
| 30 | IKBKE | 1.28132661 |
| 31 | IRAK4 | 1.24895990 |
| 32 | ZAP70 | 1.22192870 |
| 33 | IKBKB | 1.21757883 |
| 34 | CSK | 1.21181779 |
| 35 | MAP3K11 | 1.18796736 |
| 36 | CSF1R | 1.18546258 |
| 37 | BTK | 1.17770219 |
| 38 | MATK | 1.07830207 |
| 39 | MST4 | 1.05747600 |
| 40 | SIK1 | 1.04701391 |
| 41 | MAPK7 | 0.99623154 |
| 42 | TRIM28 | 0.98592002 |
| 43 | CDC42BPA | 0.98073223 |
| 44 | RIPK4 | 0.97290283 |
| 45 | VRK2 | 0.96509440 |
| 46 | MAP2K2 | 0.94732983 |
| 47 | TAOK2 | 0.92811496 |
| 48 | DAPK1 | 0.90576886 |
| 49 | MOS | 0.89755796 |
| 50 | LYN | 0.88564806 |
| 51 | SMG1 | 0.88429584 |
| 52 | PRKD2 | 0.86826385 |
| 53 | LATS1 | 0.86363953 |
| 54 | JAK1 | 0.83763966 |
| 55 | ADRBK2 | 0.82854309 |
| 56 | MAP3K3 | 0.81742493 |
| 57 | CHUK | 0.76825963 |
| 58 | CDK4 | 0.76604814 |
| 59 | CDK12 | 0.76576001 |
| 60 | CDK9 | 0.76104376 |
| 61 | IRAK1 | 0.75485554 |
| 62 | MAP2K3 | 0.74648149 |
| 63 | NME2 | 0.74518936 |
| 64 | MAP3K10 | 0.70529450 |
| 65 | RPS6KA4 | 0.68783607 |
| 66 | CDK19 | 0.68730979 |
| 67 | MAP2K7 | 0.63838809 |
| 68 | MAPKAPK2 | 0.61891284 |
| 69 | LCK | 0.61613202 |
| 70 | HCK | 0.59579842 |
| 71 | CAMKK2 | 0.58822822 |
| 72 | JAK3 | 0.58454558 |
| 73 | SYK | 0.58145176 |
| 74 | NLK | 0.57015717 |
| 75 | TGFBR2 | 0.53309192 |
| 76 | TAOK1 | 0.50477920 |
| 77 | FYN | 0.50359174 |
| 78 | TTN | 0.47202741 |
| 79 | FGFR4 | 0.45544893 |
| 80 | DYRK1B | 0.44179436 |
| 81 | SRPK1 | 0.43151037 |
| 82 | MAP2K6 | 0.41575879 |
| 83 | LRRK2 | 0.40821226 |
| 84 | ITK | 0.40041387 |
| 85 | MAPK11 | 0.39498712 |
| 86 | MST1R | 0.39062008 |
| 87 | PRKCZ | 0.34793660 |
| 88 | MAPK15 | 0.34121999 |
| 89 | JAK2 | 0.31531525 |
| 90 | RPS6KA2 | 0.31433487 |
| 91 | DYRK2 | 0.30953288 |
| 92 | MET | 0.30842681 |
| 93 | RPS6KA6 | 0.30817312 |
| 94 | DAPK2 | 0.30691258 |
| 95 | ADRBK1 | 0.29073333 |
| 96 | MAPK3 | 0.28643457 |
| 97 | CAMKK1 | 0.28487469 |
| 98 | MARK3 | 0.27861251 |
| 99 | NEK6 | 0.27842980 |
| 100 | HIPK2 | 0.27586563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.16262648 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.82998064 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.60755159 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.42530777 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37166601 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.31516496 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.27769993 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.99013805 |
| 9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.90429352 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.89043691 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.86330302 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.85820476 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85576157 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.80125222 |
| 15 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.75672558 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75450515 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74393261 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.70968731 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68901275 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66647933 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64843844 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.62030745 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60818399 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60533149 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.58515515 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.57433430 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57296047 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.56269445 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54087420 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.51098574 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50098885 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.45919266 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.44464172 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38078574 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36925552 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.35817185 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.32969065 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.29422892 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.28143051 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25902912 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24254734 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21885380 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18517962 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15257180 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15073849 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12752065 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09041592 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 1.08878779 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08781087 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05220902 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01737070 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.01248587 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00989514 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00256821 |
| 55 | Malaria_Homo sapiens_hsa05144 | 1.00074401 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98540360 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98466604 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.97207645 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93282561 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91919027 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88305672 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87396180 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87361445 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84127520 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.82572062 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81891965 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79043442 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73305089 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72323541 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71978424 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71115918 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61832641 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60835203 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54491709 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53826463 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50112010 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47172130 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46051716 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43380552 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42616956 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41647265 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40811447 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38696326 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35708674 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33724318 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31963496 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.29731823 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.28181061 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26694329 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26208555 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.25443574 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24828047 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.24670740 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24149221 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23112159 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21695329 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21446091 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19447827 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18231746 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18207770 |

